Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

No improvement in cognition seen with CERE-120 in Parkinson's disease patients

Feb. 8, 2008

Promising antitumor effects with novel anti-HAAH antibody in preclinical studies

Feb. 7, 2008

Novel atypical antipsychotic drug profiled at Neurosearch

Feb. 6, 2008

PHOENIX 1 results show long-term efficacy of ustekinumab in psoriasis

Feb. 6, 2008

NK-012 evaluated in phase I study in advanced cancer patients

Feb. 5, 2008

Volociximab-gemcitabine combination feasible in metastatic pancreatic cancer

Feb. 1, 2008

Study finds endoscopic ultrasound-guided delivery of BrachySil safe

Jan. 31, 2008

1018-ISS safely combined with irinotecan-cetuximab in colorectal cancer

Jan. 31, 2008

No objective responses seen with tremelimumab in gastric, esophageal adenocarcinoma

Jan. 30, 2008

Phase II dose of E-7974 in 21-day schedule determined in solid tumor patients

Jan. 30, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...